Authors:
Jeffery, KJM
Usuku, K
Hall, SE
Matsumoto, W
Taylor, GP
Procter, J
Bunce, M
Ogg, GS
Welsh, KI
Weber, JN
Lloyd, AL
Nowak, MA
Nagai, M
Kodama, D
Izumo, S
Osame, M
Bangham, CRM
Citation: Kjm. Jeffery et al., HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy, P NAS US, 96(7), 1999, pp. 3848-3853
Authors:
Kalams, SA
Goulder, PJ
Shea, AK
Jones, NG
Trocha, AK
Ogg, GS
Walker, BD
Citation: Sa. Kalams et al., Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia withhighly active antiretroviral therapy, J VIROLOGY, 73(8), 1999, pp. 6721-6728
Authors:
Dorrell, L
Dong, T
Ogg, GS
Lister, S
McAdam, S
Rostron, T
Conlon, C
McMichael, AJ
Rowland-Jones, SL
Citation: L. Dorrell et al., Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa, J VIROLOGY, 73(2), 1999, pp. 1708-1714
Authors:
Ogg, GS
Kostense, S
Klein, MR
Jurriaans, S
Hamann, D
McMichael, AJ
Miedema, F
Citation: Gs. Ogg et al., Longitudinal phenotypic analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes: Correlation with disease progression, J VIROLOGY, 73(11), 1999, pp. 9153-9160
Authors:
Dyer, WB
Ogg, GS
Demoitie, MA
Jin, X
Geczy, AF
Rowland-Jones, SL
McMichael, AJ
Nixon, DF
Sullivan, JS
Citation: Wb. Dyer et al., Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney blood bank cohort patients infected with nef-defective HIV type 1, J VIROLOGY, 73(1), 1999, pp. 436-443
Authors:
Ogg, GS
Jin, X
Bonhoeffer, S
Moss, P
Nowak, MA
Monard, S
Segal, JP
Cao, Y
Rowland-Jones, SL
Hurley, A
Markowitz, M
Ho, DD
McMichael, AJ
Nixon, DF
Citation: Gs. Ogg et al., Decay kinetics of human immunodeficiency virus-specific effector cytotoxicT lymphocytes after combination antiretroviral therapy, J VIROLOGY, 73(1), 1999, pp. 797-800
Authors:
Spiegel, HML
DeFalcon, E
Ogg, GS
Larsson, M
Beadle, TJ
Tao, P
McMichael, AJ
Bhardwaj, N
O'Callaghan, C
Cox, WI
Krasinski, K
Pollack, H
Borkowsky, W
Nixon, DE
Citation: Hml. Spiegel et al., Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in children, J INFEC DIS, 180(2), 1999, pp. 359-368
Authors:
Whelan, JA
Dunbar, PR
Price, DA
Purbhoo, MA
Lechner, F
Ogg, GS
Griffiths, G
Phillips, RE
Cerundolo, V
Sewell, AK
Citation: Ja. Whelan et al., Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent, J IMMUNOL, 163(8), 1999, pp. 4342-4348
Authors:
Dunbar, PR
Chen, JL
Chao, D
Rust, N
Teisserenc, H
Ogg, GS
Romero, P
Weynants, P
Cerundolo, V
Citation: Pr. Dunbar et al., Cutting edge: Rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma, J IMMUNOL, 162(12), 1999, pp. 6959-6962
Authors:
Maini, MK
Boni, C
Ogg, GS
King, AS
Reignat, S
Lee, CK
Larrubia, JR
Webster, GJM
McMichael, AJ
Ferrari, C
Williams, R
Vergani, D
Bertoletti, A
Citation: Mk. Maini et al., Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection, GASTROENTY, 117(6), 1999, pp. 1386-1396